Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AstraZeneca Pharma India Limited ( (IN:ASTRAZEN) ) has issued an announcement.
AstraZeneca Pharma India Limited has announced that the record date for determining shareholders’ entitlement to the final dividend for the financial year 2024-25 is set for July 18, 2025. The final dividend, pending shareholder approval, is scheduled to be paid or dispatched by September 12, 2025, reflecting the company’s commitment to returning value to its shareholders.
More about AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited operates in the pharmaceutical industry, focusing on the development and distribution of medicines and healthcare products. The company is part of the global AstraZeneca group, which is known for its innovative treatments in various therapeutic areas.
Average Trading Volume: 3,717
Current Market Cap: 232.4B INR
For a thorough assessment of ASTRAZEN stock, go to TipRanks’ Stock Analysis page.